Cord Blood Transplantation in Children and Young Adults With Blood Cancer
for Acute Myelogenous Leukemia
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: Up to 26
Code: NCT07566377·Phase 2·Recruiting
Pediatric oncology Clinical Trials in New York, NY
As of June 2026, 34 paid clinical trials are recruiting for Pediatric oncology in New York, New York. Pediatric oncology trials evaluate age-appropriate dosing of targeted therapies, immune cell therapies, and novel agents for childhood leukemias, sarcomas, neuroblastoma, and brain tumors. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
34 clinical trials for Pediatric oncology
·Clear filters·↓ Download CSVEvaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
for Ewing Sarcoma
4 locations incl. Los Angeles
Sponsor: Amgen
Sex: All·Age: 2+
Code: NCT07297979·Phase 1·Recruiting
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
for Osteosarcoma
Drug: Trametinib
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 6 - 49
Code: NCT07477457·Phase 2·Recruiting
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
for Acute Lymphoblastic Leukemia
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 40+
Code: NCT07400029·Phase 2·Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
for Leukemia
Drug: Mezigdomide
10 locations incl. Duarte
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 12+
Code: NCT07356154·Phase 1, Phase 2·Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
for Advanced Solid Tumors
6 locations incl. Duarte
Sponsor: SEED Therapeutics, Inc.
Sex: All·Age: 16+
Code: NCT07197554·Phase 1·Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
for B-cell Acute Lymphoblastic Leukemia
17 locations incl. Los Angeles
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 6 Months - 25
Code: NCT06395103·Phase 1, Phase 2·Recruiting
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
for High-risk Neuroblastoma
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18 Months - 19
Code: NCT06528496·Phase 2·Recruiting
PediRISE Feasibility
for Pediatric Cancer
4 locations incl. San Francisco
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: Up to 17
Code: NCT06283251·Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for Ganglioneuroblastoma, Nodular
156 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: Up to 30
Code: NCT06172296·Phase 3·Recruiting
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
for Acute Lymphoblastic Leukemia
1 location in New York
Sponsor: Columbia University
Sex: All·Age: 5 - 21
Code: NCT05963971·Recruiting
A Study of Avutometinib for People With Solid Tumor Cancers
for Refractory Cancer
Drug: Avutometinib
2 locations incl. Atlanta
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 3 - 30
Code: NCT06104488·Phase 1·Recruiting
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
for Neuroblastoma
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: All ages
Code: NCT06057948·Phase 2·Recruiting
SPEARHEAD-3 Pediatric Study
for Synovial Sarcoma
10 locations incl. Palo Alto
Sponsor: USWM CT, LLC
Sex: All·Age: 2 - 21
Code: NCT05642455·Phase 1, Phase 2·Recruiting
Lurbinectedin in FET-Fused Tumors
for Ewing Sarcoma
Drug: Lurbinectedin
6 locations incl. Los Angeles
Sponsor: Children's Hospital of Philadelphia
Sex: All·Age: 10+
Code: NCT05918640·Phase 1, Phase 2·Recruiting
European Prospective Investigation Into Childhood Cancer
for Acute Lymphoblastic Leukemia
1 location in New York
Sponsor: Columbia University
Sex: All·Age: 3 - 21
Code: NCT05375617·Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
for Refractory Ewing Sarcoma
Drug: Lurbinectedin
14 locations incl. Los Angeles
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 2 - 30
Code: NCT05734066·Phase 1, Phase 2·Recruiting
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
for Acute Lymphoblastic Leukemia
1 location in New York
Sponsor: Columbia University
Sex: All·Age: 3 - 18
Code: NCT05929976·Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
for Acute Lymphoblastic Leukemia
746 locations incl. Anchorage
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 40 - 75·Accepts healthy volunteers
Code: NCT05334069·Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
for Acute Lymphoblastic Leukemia
164 locations incl. Birmingham
Sponsor: PedAL BCU, LLC
Sex: All·Age: Up to 22
Code: NCT04726241·Phase 1, Phase 2·Recruiting
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
for Acute Myeloid Leukemia
3 locations incl. Atlanta
Sponsor: Meryx, Inc.
Sex: All·Age: 12+
Code: NCT04872478·Phase 1·Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for Metastatic Malignant Neoplasm in the Lung
219 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 50
Code: NCT05235165·Phase 3·Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
for Colorectal Carcinoma
21 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 12 Months - 30
Code: NCT04851119·Phase 1, Phase 2·Recruiting
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
for Neuroblastoma
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: All ages·Accepts healthy volunteers
Code: NCT04936529·Phase 2·Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
for Acute Myeloid Leukemia
Drug: Revumenib
22 locations incl. Duarte
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 30 Days+
Code: NCT04065399·Phase 1, Phase 2·Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
for Acute Myeloid Leukemia
11 locations incl. Duarte
Sponsor: Orca Biosystems, Inc.
Sex: All·Age: 12 - 78
Code: NCT03802695·Phase 1·Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for Ewing Sarcoma
23 locations incl. Scottsdale
Sponsor: Inhibrx Biosciences, Inc
Sex: All·Age: 12 - 85
Code: NCT03715933·Phase 1·Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
for Ganglioneuroblastoma
152 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 365 Days - 30
Code: NCT03126916·Phase 3·Recruiting
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
for Neuroblastoma
6 locations incl. Gainesville
Sponsor: Y-mAbs Therapeutics
Sex: All·Age: 1+
Code: NCT03363373·Phase 2·Recruiting
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
for Bone Sarcoma
5 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 4+
Code: NCT03442465·Recruiting
Neuroblastoma Maintenance Therapy Trial
for Neuroblastoma
42 locations incl. Birmingham
Sponsor: Giselle Sholler
Sex: All·Age: 1 - 30
Code: NCT02679144·Phase 2·Recruiting
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
for Sarcoma
5 locations incl. Washington D.C.
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 4 Weeks+·Accepts healthy volunteers
Code: NCT01109394·Recruiting
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
for Neuroblastoma
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 1+
Code: NCT00107289·Phase 2·Recruiting
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
for Neuroblastoma
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: All ages
Code: NCT00588068·Recruiting
About research studies in New York
New York has approximately 3,501 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in New York
Researchers run research studies in New York, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Cancer Center | Breast Cancer, Prostate Cancer, Endometrial Cancer | 481 |
| NYU Langone Health | Lung Cancer, Prostate Cancer, Cardiovascular Diseases | 309 |
| Icahn School of Medicine at Mount Sinai | Myelofibrosis, Prostate Cancer, Advanced Solid Tumor | 263 |
| Columbia University Irving Medical Center | Obesity, Insulin Resistance, Prostate Cancer | 187 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | Breast Cancer, Multiple Myeloma, Metastatic Breast Cancer | 153 |
| Weill Cornell Medicine | Heart Failure, Depression, Prostate Cancer | 141 |
| Columbia University Medical Center | Breast Cancer, Advanced Solid Tumor, Coronary Artery Disease | 135 |
| Mount Sinai Hospital | Acute Myeloid Leukemia, Heart Failure, Anatomic Stage IV Breast Cancer AJCC v8 | 132 |
| Columbia University | Amyotrophic Lateral Sclerosis, Colorectal Cancer, Multiple Myeloma | 113 |
| Hospital for Special Surgery | Opioid Use, Rheumatoid Arthritis, Systemic Lupus Erythematosus | 69 |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Solid Neoplasm, Stage IV Renal Cell Cancer AJCC v8 | 64 |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Acute Myeloid Leukemia | 61 |
| Lenox Hill Hospital | Atrial Fibrillation, Anatomic Stage II Breast Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma | 55 |
| Weill Cornell Medical College | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 49 |
| Mount Sinai | Ovarian Cancer, AML, Advanced Solid Tumors | 44 |
| Mount Sinai West | Breast Cancer, Intracerebral Hemorrhage, Anatomic Stage II Breast Cancer AJCC v8 | 43 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | Breast Cancer, Prostate Cancer, Adult Cancer Patients | 38 |
| NYP/Weill Cornell Medical Center | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8 | 35 |
| New York University | Inflammatory Bowel Disease (IBD), Adenine Phosphoribosyltransferase Deficiency, Arrhythmogenic Right Ventricular Cardiomyopathy | 33 |
| Memorial Sloan-Kettering Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer | 27 |
| Mount Sinai Chelsea | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 24 |
| Manhattan Eye Ear and Throat Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 22 |
| NYU Langone | Gout, Acute Gastrointestinal Bleeding, Acute Gout Flare | 21 |
| Montefiore Medical Center | Mitral Regurgitation, Coronary Artery Disease, AML, Adult | 20 |
| NYU Langone Medical Center | Mesothelioma, NSCLC, Non Small Cell Lung Cancer | 20 |
Active & Upcoming Studies in New York (2026)
Recruiting trials in New York grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (1,213 active studies)
- Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) · Phase 2 · Columbia University
- Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening · VA Office of Research and Development
Neurology & pain (207 active studies)
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau · Phase 1 · Columbia University
- Opioid Dispenser for Microdiscectomy/Laminectomy · Hospital for Special Surgery, New York
Cardiovascular (194 active studies)
Mental health & behavior (105 active studies)
- Permanent Supportive Housing Overdose Prevention+ Study · NYU Langone Health
- Technology dRiven Enhancement to Engage & Connect · Weill Medical College of Cornell University
Diabetes & metabolic (102 active studies)
- South Asians With Type 2 Diabetes at Risk for Depression · NYU Langone Health
- Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · Columbia University
HIV / STI (48 active studies)
Pediatric (34 active studies)
Vaccines (22 active studies)
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction · Phase 2 · Icahn School of Medicine at Mount Sinai
- Harnessing Optimism and Perseverance in the Face of Long COVID-Español · Icahn School of Medicine at Mount Sinai
Eye & vision (18 active studies)
- Know Your Pressures NYC · Columbia University
- Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) · Phase 1 · Life Biosciences Inc.
Common conditions studied in New York
- Breast Cancer (93 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Prostate Cancer (73 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Multiple Myeloma (51 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Solid Tumor (42 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ovarian Cancer (42 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Colorectal Cancer (39 active studies). Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors.
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in New York. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in New York
Hipa.ai aggregates every recruiting study in New York from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,501 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (93), Prostate Cancer (73), Multiple Myeloma (51), Advanced Solid Tumor (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,213), Neurology & pain (207), Cardiovascular (194). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in New York
The Bronx, NY(619)Rochester, NY(507)Buffalo, NY(465)Commack, NY(322)Harrison, NY(297)Uniondale, NY(224)Brooklyn, NY(208)Syracuse, NY(202)Stony Brook, NY(201)Albany, NY(169)Lake Success, NY(165)New Hyde Park, NY(150)Mineola, NY(127)Manhasset, NY(112)Valhalla, NY(107)Rockville Centre, NY(80)Staten Island, NY(78)East Syracuse, NY(58)Westbury, NY(46)Mount Kisco, NY(44)White Plains, NY(44)Amherst, NY(40)Roslyn, NY(37)Great Neck, NY(36)Bay Shore, NY(34)Webster, NY(33)Flushing, NY(32)Glens Falls, NY(32)Poughkeepsie, NY(30)Queens, NY(28)Ithaca, NY(27)Shirley, NY(27)Sleepy Hollow, NY(25)Long Island City, NY(23)Port Jefferson Station, NY(23)Garden City, NY(21)Williamsville, NY(21)Cooperstown, NY(19)Greenlawn, NY(18)Camillus, NY(17)Hawthorne, NY(17)Verona, NY(17)West Islip, NY(17)Binghamton, NY(16)Jamaica, NY(16)Middletown, NY(15)Oswego, NY(15)East White Plains, NY(14)New Windsor, NY(14)Cedarhurst, NY(13)Laurelton, NY(13)Liverpool, NY(13)Rego Park, NY(13)Clifton Park, NY(12)Manhattan, NY(12)Utica, NY(12)East Hills, NY(11)Glen Oaks, NY(11)Riverhead, NY(11)Kew Gardens, NY(10)